The HWP Group (HWP), a medical communications and strategic consulting partner to the life sciences industry, announced it has acquired Global Market Access Solutions (GMAS), a market access and health economics consultancy with global operations. The transaction marks a key milestone in HWP’s long-term growth strategy.
With the addition of GMAS, HWP expands its capabilities in market access strategy, health economics and outcomes research (HEOR), pricing and payer insights, evidence synthesis, and lifecycle value strategy. The combined organization will support clients across the full product lifecycle, from early clinical development through launch, reimbursement, and sustained patient access.
As healthcare systems face growing resource constraints, payers and health systems are increasingly requiring robust clinical and economic evidence to support reimbursement and funding decisions. GMAS brings experience in articulating the economic value of therapeutic innovations through a range of economic evaluation analytic frameworks, helping inform healthcare delivery and support commercial outcomes.
The acquisition further positions HWP as an integrated strategic partner to pharmaceutical and biotechnology companies operating in complex global markets, where demonstrating both clinical benefit and economic value is critical to achieving reimbursement, adoption, and long-term patient impact.
KEY QUOTES:
“With this acquisition, HWP takes a decisive step forward in our mission to help clients bridge the gap between scientific innovation and real-world patient access. Market access and health economics are no longer optional—they are foundational. By integrating GMAS’ capabilities into HWP, we can now help clients not only tell a compelling scientific story, but also prove economic value to payers and health systems—ensuring faster, broader, and more sustainable patient access.”
Jani Hegarty, Chief Executive Officer and Founder, The HWP Group
“Nikos Kotsopoulos, PhD, and I are thrilled to join The HWP Group and continue our efforts to improve patient access to medications. This change allows us to scale our market access and HEOR expertise within a platform that shares our commitment to rigor, strategy, and partnership. Together, we are exceptionally well positioned to help life sciences companies ensure their innovations are not only approved, but reimbursed, accessible, and impactful.”
Mark Connolly, PhD, Managing Partner, Global Market Access Solutions
“From the outset of our partnership with HWP, we believed in the firm’s vision to build a differentiated, integrated services platform for the life sciences industry. The acquisition of GMAS is a natural and highly strategic next step, adding critical market access and HEOR capabilities that are essential to commercial success today. We are proud to continue supporting the growth of HWP and look forward to the value this combination will deliver to clients and patients alike.”
Luis Gonzalez, Senior Partner, NMS Capital
